ALN-4285 Investigational RNAi program undergoing Phase 1 clinical development in healthy volunteers; Alnylam’s maintained public pipeline does not specify a disease indication.
Visit productCosigns Received
Be the first Cosign
Put your name behind ALN-4285.
Add it to your Products I use list and share why you use it.